Topchoice Medical Future Growth
Future criteria checks 4/6
Topchoice Medical is forecast to grow earnings and revenue by 24.7% and 14.5% per annum respectively. EPS is expected to grow by 23.5% per annum. Return on equity is forecast to be 17% in 3 years.
Key information
24.7%
Earnings growth rate
23.5%
EPS growth rate
Healthcare earnings growth | 23.6% |
Revenue growth rate | 14.5% |
Future return on equity | 17.0% |
Analyst coverage | Good |
Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,539 | N/A | 1,283 | N/A | 1 |
12/31/2025 | 4,172 | 940 | 963 | 1,117 | 11 |
12/31/2024 | 3,482 | 754 | 612 | 1,028 | 12 |
12/31/2023 | 2,908 | 587 | 486 | 922 | 11 |
9/30/2023 | 2,764 | 545 | 421 | 784 | N/A |
6/30/2023 | 2,763 | 557 | 243 | 704 | N/A |
3/31/2023 | 2,739 | 551 | 382 | 762 | N/A |
12/31/2022 | 2,719 | 548 | 249 | 670 | N/A |
9/30/2022 | 2,784 | 598 | 224 | 771 | N/A |
6/30/2022 | 2,781 | 648 | 394 | 867 | N/A |
3/31/2022 | 2,804 | 705 | 399 | 876 | N/A |
12/31/2021 | 2,781 | 703 | 572 | 939 | N/A |
9/30/2021 | 2,742 | 713 | 673 | 930 | N/A |
6/30/2021 | 2,652 | 698 | 721 | 897 | N/A |
3/31/2021 | 2,523 | 676 | 723 | 907 | N/A |
12/31/2020 | 2,088 | 493 | 538 | 708 | N/A |
9/30/2020 | 1,992 | 466 | 497 | 628 | N/A |
6/30/2020 | 1,838 | 404 | 389 | 545 | N/A |
3/31/2020 | 1,733 | 352 | 332 | 473 | N/A |
12/31/2019 | 1,931 | 466 | 531 | 659 | N/A |
9/30/2019 | 1,803 | 456 | 545 | 624 | N/A |
6/30/2019 | 1,708 | 405 | 517 | 574 | N/A |
3/31/2019 | 1,632 | 365 | 514 | 576 | N/A |
12/31/2018 | 1,546 | 332 | 229 | 469 | N/A |
9/30/2018 | 1,473 | 310 | 218 | 465 | N/A |
6/30/2018 | 1,357 | 263 | 163 | 413 | N/A |
3/31/2018 | 1,246 | 235 | 101 | 353 | N/A |
12/31/2017 | 1,180 | 217 | 278 | 347 | N/A |
9/30/2017 | 1,108 | 193 | 206 | 304 | N/A |
6/30/2017 | 1,006 | 153 | N/A | 241 | N/A |
3/31/2017 | 946 | 143 | N/A | 207 | N/A |
12/31/2016 | 879 | 136 | N/A | 161 | N/A |
9/30/2016 | 844 | 128 | N/A | 123 | N/A |
6/30/2016 | 801 | 128 | N/A | 141 | N/A |
3/31/2016 | 790 | 129 | N/A | 132 | N/A |
12/31/2015 | 763 | 124 | N/A | 191 | N/A |
9/30/2015 | 715 | 142 | N/A | 193 | N/A |
6/30/2015 | 670 | 127 | N/A | 152 | N/A |
3/31/2015 | 612 | 117 | N/A | 143 | N/A |
12/31/2014 | 584 | 110 | N/A | 129 | N/A |
9/30/2014 | 554 | 109 | N/A | 130 | N/A |
6/30/2014 | 518 | 103 | N/A | 123 | N/A |
3/31/2014 | 488 | 103 | N/A | 120 | N/A |
12/31/2013 | 463 | 100 | N/A | 134 | N/A |
9/30/2013 | 432 | 98 | N/A | 116 | N/A |
6/30/2013 | 409 | 95 | N/A | 114 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600763's forecast earnings growth (24.7% per year) is above the savings rate (2.9%).
Earnings vs Market: 600763's earnings (24.7% per year) are forecast to grow faster than the CN market (23.9% per year).
High Growth Earnings: 600763's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 600763's revenue (14.5% per year) is forecast to grow faster than the CN market (14.3% per year).
High Growth Revenue: 600763's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600763's Return on Equity is forecast to be low in 3 years time (17%).